CSS LLC’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-17,278
Closed -$17K 690
2017
Q4
$17K Hold
17,278
﹤0.01% 591
2017
Q3
$26K Hold
17,278
﹤0.01% 599
2017
Q2
$21K Hold
17,278
﹤0.01% 618
2017
Q1
$19K Hold
17,278
﹤0.01% 612
2016
Q4
$18K Hold
17,278
﹤0.01% 672
2016
Q3
$18K Hold
17,278
﹤0.01% 699
2016
Q2
$25K Hold
17,278
﹤0.01% 678
2016
Q1
$21K Hold
17,278
﹤0.01% 650
2015
Q4
$21K Hold
17,278
﹤0.01% 666
2015
Q3
$28K Hold
17,278
﹤0.01% 720
2015
Q2
$36K Hold
17,278
﹤0.01% 732
2015
Q1
$51K Hold
17,278
﹤0.01% 672
2014
Q4
$54K Hold
17,278
﹤0.01% 743
2014
Q3
$59K Hold
17,278
﹤0.01% 728
2014
Q2
$45K Hold
17,278
﹤0.01% 719
2014
Q1
$49K Sell
17,278
-1,000
-5% -$3.02K ﹤0.01% 643
2013
Q4
$50K Buy
+18,278
New +$51.3K ﹤0.01% 642

Other funds holding CELGZ

CSS LLC's CELGZ Position: Q1 2018 in Review

CSS LLC sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q1 2018, closing a stake of 17,278 shares — an estimated $17K sold.

CSS LLC first reported a position in CELGZ in Q4 2013 and held it in 17 quarters. The position peaked at $59K in Q3 2014. 21 funds tracked by Wall St. Rank hold CELGZ as of Q1 2018.

  • CSS LLC reported no remaining Celgene Corporation Contingent Value Rights position as of Q1 2018 after selling out during the quarter.
  • CSS LLC sold 17,278 Celgene Corporation Contingent Value Rights shares in Q1 2018, an estimated $17K.
  • CSS LLC first reported a position in Celgene Corporation Contingent Value Rights in Q4 2013 and held it in 17 quarters.
  • CSS LLC's Celgene Corporation Contingent Value Rights position peaked at $59K in Q3 2014.
  • 21 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q1 2018.

Based on CSS LLC's 13F filing for Q1 2018, filed 15 May 2018.